Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2024Annals of the Rheumatic Diseases

Ab0590 Correlation Between Cumulative Methotrexate Dose, Metabolic Syndrome and Hepatic Fibrosis Detected by Fibroscan in Patients Receiving Methotrexate in Rheumatoid Arthritis in Comparison With Psoriatic Arthritis

View Full Paper
Ask AI
Bookmark
Share

Authors

RLRatchaya LertnawapanSCSoonthorn ChonprasertsukSSSith Siramolpiwat

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lertnawapan et al. (2024) studied this question.

synapsesocial.com/papers/68e671b5b6db6435875fbc95https://doi.org/10.1136/annrheumdis-2024-eular.2747
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Assessment of liver fibrosis by transient elastography and procollagen III amino terminal propeptide in rheumatoid arthritis patients treated with methotrexate2024
  2. 2Hepatic steatosis and its associated factors in patients with rheumatoid arthritis based on quantitative assessment by ultrasound-derived fat fraction2026
  3. 3P118 Assessment of methotrexate-induced liver toxicity in patients with inflammatory rheumatic diseases: an observational study based on FIB-4 and FibroScan2026
  4. 4Effect of Methotrexate Discontinuation on Psoriatic Patients with Significant Liver Fibrosis2025
  5. 5P018 The double-edged sword: weighing methotrexate’s benefits against hepatic toxicity - a study to assess long term safety of methotrexate2026